(Press-News.org) At the end of 2022, the federal government eliminated the “X waiver,” a major hurdle to providing addiction treatment, but progress needs to be continued, according to the authors of a new Perspective piece published in the New England Journal of Medicine. The X waiver required a special license and uncompensated training for physicians and other prescribers, creating a regulatory barrier to offering lifesaving buprenorphine treatment for opioid use disorder. Ending the X, the authors write, is necessary but not sufficient to achieve overdose-prevention goals.
Sarah Wakeman, MD, Medical Director for Substance Use Disorder at Mass General Brigham, and her co-author Leo Beletsky, JD, MPH, University of California, San Diego School of Medicine, call for several additional measures to expand access. These include:
Mainstreaming addiction education: Rather than the 8-hour training the Drug Enforcement Administration is now requiring of all clinicians who prescribe controlled substances, incorporate education about addiction during medical school, residency, and other training programs.
Expanding methadone access: Rethinking methadone regulations, including transitioning stable patients to office-based care with general practitioners.
Investing in the addiction treatment workforce: Federally fund training programs, including addiction medicine fellowship programs for physicians and training in addiction programs for nurse practitioners, social workers, and mental health counselors.
“The X waiver was one example of an onerous and unnecessary barrier to a lifesaving intervention, but there are many others, including methadone regulations and policies obstructing access to harm-reduction services,” said Wakeman. “We believe the federal government should continue its important progress in expanding access to medication for substance use disorder by rethinking methadone regulations.”
Paper cited: Wakeman SE “Beyond the X — Next Steps in Policy Reforms to Address the Overdose Crisis” NEJM DOI: 10.1056/NEJMp2301479
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds in medicine to make life-changing impact for patients in our communities and people around the world.
Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services.
Mass General Brigham is a non-profit organization that is committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. For more information, please visit massgeneralbrigham.org.
END
Mass General Brigham expert calls for reforms to address the overdose crisis
2023-05-01
ELSE PRESS RELEASES FROM THIS DATE:
New metric allows researchers to better understand soft material behavior
2023-05-01
CHAMPAIGN, Ill. — The mechanics behind the collapse of soft materials structure have befuddled researchers for decades. In a new study, researchers uncover a metric that finally correlates microscopic-level processes with what is seen at the macroscopic level.
The new metric is poised to help bring advances to various materials engineering challenges – ranging from the formulation of better 3D printing inks, the construction of wearable flexible electronics and sensors, the accurate printing of biomedical implants, to helping control landslides and avalanches, and ...
Boston University Chobanian & Avedisian School of Medicine names Educators of the Year
2023-05-01
(Boston)–Five Boston University Chobanian & Avedisian School of Medicine faculty have been honored as 2023 Educators of the Year by the School’s Awards Committee. Nominated by students and faculty, the annual awards recognize School of Medicine educators who provide excellence in teaching and mentoring.
This year’s recipients are Ricardo Cruz, MD, MPH, Educator of the Year, Preclerkship; Julia Bartolomeo, MD, Educator of the Year, Clerkship; Lillian Sosa, MS, CGC, Educator of the Year in MA/MS Programs; Douglas Rosene, PhD, ...
BU researcher receives prestigious Fulbright Scholar Award
2023-05-01
(Boston)—Sean D. Tallman, PhD, RPA, assistant professor of anatomy & neurobiology at Boston University Chobanian & Avedisian School of Medicine, has been awarded a Fulbright Scholar Award. This award allows U.S. academics to engage in multi-country, trans-regional projects.
Tallman will travel to South Africa for 10 months to conduct human skeletal biology research for his project, "Assessing the Effects of Disadvantage and Ancestry in Skeletal Health and Forensic Medicine" at the University of Cape Town and Stellenbosch University.
Tallman ...
Lithography-free photonic chip offers speed and accuracy for artificial intelligence
2023-05-01
Photonic chips have revolutionized data-heavy technologies. On their own or in concert with traditional electronic circuits, these laser-powered devices send and process information at the speed of light, making them a promising solution for artificial intelligence’s data-hungry applications.
In addition to their incomparable speed, photonic circuits use significantly less energy than electronic ones. Electrons move relatively slowly through hardware, colliding with other particles and generating heat, while photons flow without losing energy, ...
Another pharmacological approach fails to diminish delirium severity or duration
2023-05-01
INDIANAPOLIS – A new study conducted by researchers from Regenstrief Institute and the universities of South Carolina and Indiana has found that the most commonly prescribed blood pressure medications, taken for at least six months prior to an intensive care unit (ICU) admission, did not protect against developing delirium in the ICU, regardless of patient age, gender, race, co-morbidities or insurance status.
Delirium, an acute brain failure, affects approximately seven million hospitalized patients in the U.S. annually and is associated with longer hospital and ICU length of stay, higher likelihood ...
Children’s Hospital Los Angeles researchers uncover new clues to origins of the most common pediatric kidney cancer
2023-05-01
[LOS ANGELES (May 1, 2023) — While Wilms tumor—also known as nephroblastoma-- is rare, it is the most prevalent childhood kidney cancer. Researchers at Children’s Hospital Los Angeles have now pinpointed a disruption in early kidney progenitor cell development that can be linked to the formation of Wilms tumor.
In a study published in Advanced Science, researchers at the GOFARR Laboratory in Urology compared kidney progenitor cells from a tumor with precursor cells from a healthy kidney. Normally, these precursor cells mature into kidney cells, but when their early development is dysregulated, they behave like cancer stem cells.
While most children ...
Bacteria could make salmon healthier
2023-05-01
Researchers, including from NTNU, are breeding bacteria-free fish fry. This pursuit is more important than you might think.
“We’re managing to keep the fry bacteria-free for up to 12 weeks after the eggs hatch,” says Ingrid Bakke. She is a professor at NTNU’s Department of Biotechnology and Food Science.
This step has now helped researchers on the trail to figuring out how bacteria and fish affect each other. Understanding their interaction could one day also lead to a method ...
Pusan National University study suggests that hospital admissions for acute kidney injury may be linked to air pollution
2023-05-01
Acute kidney injury (AKI) is a clinical syndrome characterized by a decrease in kidney function. AKI is very common in the United States' Medicare population, particularly among hospital intensive care unit (ICU) admissions. Furthermore, AKI is associated with the incidence of end-stage renal disease, which eventually increases the burden of long-term care, higher health-care costs, and increased mortality.
In several instances, kidney diseases have been linked to air pollution exposure. Inhaling air pollutants, including gases like nitrogen dioxide (NO2), ozone (O3), and fine particulate matter (PM2.5) that remains suspended in ...
PLOS expands footprint in Europe with a publishing agreement in Italy
2023-05-01
SAN FRANCISCO —The Public Library of Science (PLOS) is pleased to announce an agreement with the University of Padua to facilitate unlimited publishing across all 12 PLOS titles with no fees for researchers. This agreement encompasses PLOS’ three innovative publishing models, ensuring researchers from the University of Padua to benefit from frictionless, fee-free publishing with PLOS. This agreement represents another in the Europe, following agreements in Germany, Sweden, Ireland and the UK (Jisc).
“We are excited to expand our footprint ...
Cognitive impairment after stroke is common, and early diagnosis and treatment needed
2023-05-01
Statement Highlights:
More than half of people who survive a stroke develop cognitive impairment within the first year after their stroke, and as many as 1 in 3 may develop dementia within 5 years.
The high risk of cognitive impairment and dementia after a stroke suggests early screening is essential for determining initial treatment, such as multidisciplinary care, cognitive rehabilitation or increased physical activity. It’s also important to assess stroke survivors for cognitive changes over time to offer appropriate treatment modifications and support for longer-term care.
Cognitive impairment after stroke may fluctuate, particularly ...